id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
work_rg7an7z76ne6fmgsrnvv734rpu	G. M. M. VIDETIC	Locally advanced non-small cell lung cancer: What is the optimal concurrent chemoradiation regimen?	2012		.pdf	text/html	1253	216	63	[PDF] Locally advanced non–small cell lung cancer: What is the optimal concurrent chemoradiation regimen? Corpus ID: 38910996Locally advanced non–small cell lung cancer: What is the optimal concurrent chemoradiation regimen? The optimal chemoradiation regimen for patients with locally advanced non–small cell lung cancer (NSCLC) has yet to be defined. The effect of radiotherapy dose on survival in stage III non-small-cell lung cancer patients undergoing definitive chemoradiotherapy. Management of unresectable stage III non-small-cell lung cancer with combined-modality therapy: a review of the current literature and recommendations for treatment. Concurrent chemoradiotherapy in non-small cell lung cancer. Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology. Long term survival in stage IIIb non-small cell lung cancer (NSCLC) treated with consolidation docetaxel following concurrent chemoradiotherapy (SWOG S9504)	./cache/work_rg7an7z76ne6fmgsrnvv734rpu.pdf	./txt/work_rg7an7z76ne6fmgsrnvv734rpu.txt